SIDE EFFECTS: Low blood sugar (hypoglycemia), which can result in fatigue, hunger, irritability, confusion, headache, irregular heartbeat, and (in severe cases) loss of consciousness, seizures, coma, and even death
Batch: GF-AOD5-B241 Assay Content: 4.86 mg Purity: greater than 99.8 percent Identification by Spectrum: 986 Identification by Retention Time: 0.996 Molecular Ion Mass Identification: 1815 Da Bacterial Endotoxins: 0.009 EU/mg Total Aerobic Microbial Count: Not detected Total Yeast and Mold Count: Not detected Research Applications In controlled laboratory environments, AOD-9604 may be utilised in experimental models designed to investigate peptide signalling systems and molecular communication pathways
Endocrine systems
Providers typically reserve glycine injection for specialized needs-for instance, as part of a tailored amino-acid supplementation regimen-and treatment should only be initiated and monitored by qualified healthcare professionals in accordance with applicable laws and guidelines
Certain symptom patterns can provide clues about where the nerve irritation originates